RPTEC were maintained in Renal Epithelial Cell Basal Medium (REBM, ATCC) supplemented with 0.5% FBS, 10 nM triiodothyronine, 10 ng ml 1 rh EGF, 100 ng ml 1 hydrocortisone hemisuccinate, 5 g ml 1 rh insulin, 1 M epinephrine, 5 g ml 1 transferrin and 2.4 mM L-alanyl-L-glutamine
External resources Lupus Foundation of America - Comprehensive patient and research resources for systemic lupus erythematosus National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Lupus - NIH research and clinical information ClinicalTrials.gov - Search for current peptide and lupus clinical trials PubMed - Access peer-reviewed research on peptides and autoimmune conditions American College of Rheumatology - Professional guidelines for lupus management and research For researchers serious about optimizing peptide protocols for autoimmune support, SeekPeptides offers the most comprehensive resource available
and take a deep breath Image content: This image is available to view online
Circulation 24 , 788796 (1961)
There is no competitive inhibition at play
Many topical products can fit daily routines, but overuse does not lead to faster results
